Heterocyclic ITK inhibitors for treating inflammation and cancer
US10150783B2 · kind B2 · utility
0Cited by
12References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 31, 2017 |
| Grant date | Dec 11, 2018 |
| Priority date | — |
| Expiry date | May 31, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are heterocyclic compounds and compositions useful in the treatment of ITK mediated diseases, such as inflammation, having the structure of Formula (I): wherein R1, R2, and X are as defined in the detailed description. Methods of inhibition of ITK activity in a human or animal subject are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.